Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 21 studies | 27% ± 10% | |
| natural killer cell | 13 studies | 21% ± 3% | |
| astrocyte | 13 studies | 33% ± 13% | |
| mast cell | 11 studies | 21% ± 6% | |
| oligodendrocyte precursor cell | 11 studies | 36% ± 17% | |
| glutamatergic neuron | 10 studies | 44% ± 26% | |
| pericyte | 10 studies | 22% ± 8% | |
| microglial cell | 9 studies | 26% ± 7% | |
| fibroblast | 9 studies | 24% ± 6% | |
| GABAergic neuron | 8 studies | 41% ± 21% | |
| smooth muscle cell | 8 studies | 18% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 7 studies | 19% ± 3% | |
| retinal cone cell | 7 studies | 41% ± 11% | |
| retinal rod cell | 7 studies | 32% ± 6% | |
| adipocyte | 7 studies | 23% ± 6% | |
| macrophage | 7 studies | 26% ± 8% | |
| oligodendrocyte | 7 studies | 25% ± 7% | |
| CD16-positive, CD56-dim natural killer cell, human | 6 studies | 19% ± 2% | |
| interneuron | 6 studies | 42% ± 23% | |
| amacrine cell | 6 studies | 30% ± 10% | |
| retina horizontal cell | 6 studies | 41% ± 9% | |
| Mueller cell | 6 studies | 24% ± 7% | |
| T cell | 5 studies | 19% ± 3% | |
| B cell | 5 studies | 20% ± 3% | |
| neuron | 5 studies | 32% ± 9% | |
| retinal bipolar neuron | 5 studies | 27% ± 9% | |
| myeloid cell | 5 studies | 21% ± 4% | |
| epithelial cell | 5 studies | 36% ± 14% | |
| cardiac muscle cell | 5 studies | 40% ± 8% | |
| dendritic cell | 5 studies | 25% ± 11% | |
| endothelial cell of lymphatic vessel | 5 studies | 23% ± 4% | |
| leukocyte | 4 studies | 21% ± 3% | |
| mature NK T cell | 4 studies | 18% ± 2% | |
| granule cell | 4 studies | 24% ± 5% | |
| lymphocyte | 4 studies | 27% ± 4% | |
| OFF-bipolar cell | 4 studies | 24% ± 5% | |
| ON-bipolar cell | 4 studies | 20% ± 4% | |
| type II pneumocyte | 4 studies | 20% ± 3% | |
| goblet cell | 4 studies | 25% ± 14% | |
| naive B cell | 3 studies | 19% ± 3% | |
| non-classical monocyte | 3 studies | 23% ± 8% | |
| CD4-positive, alpha-beta T cell | 3 studies | 20% ± 3% | |
| conventional dendritic cell | 3 studies | 21% ± 5% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
| hematopoietic precursor cell | 3 studies | 23% ± 6% | |
| GABAergic interneuron | 3 studies | 23% ± 2% | |
| retinal ganglion cell | 3 studies | 43% ± 19% | |
| plasma cell | 3 studies | 29% ± 9% | |
| ciliated cell | 3 studies | 21% ± 5% | |
| GABAergic amacrine cell | 3 studies | 24% ± 3% | |
| glycinergic amacrine cell | 3 studies | 22% ± 4% | |
| rod bipolar cell | 3 studies | 30% ± 5% | |
| hepatocyte | 3 studies | 40% ± 22% | |
| muscle cell | 3 studies | 25% ± 8% | |
| type I pneumocyte | 3 studies | 20% ± 2% | |
| CD8-positive, alpha-beta T cell | 3 studies | 20% ± 4% | |
| monocyte | 3 studies | 21% ± 3% | |
| basal cell | 3 studies | 26% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 900.27 | 1445 / 1445 | 100% | 4.92 | 183 / 183 |
| lung | 100% | 1078.75 | 578 / 578 | 100% | 4.89 | 1155 / 1155 |
| ovary | 100% | 1171.07 | 180 / 180 | 100% | 4.68 | 430 / 430 |
| uterus | 100% | 1310.81 | 170 / 170 | 100% | 4.60 | 459 / 459 |
| brain | 100% | 1390.66 | 2640 / 2642 | 100% | 12.41 | 705 / 705 |
| breast | 100% | 1321.20 | 459 / 459 | 100% | 5.32 | 1117 / 1118 |
| thymus | 100% | 1633.33 | 653 / 653 | 100% | 8.00 | 604 / 605 |
| bladder | 100% | 1144.10 | 21 / 21 | 100% | 4.50 | 503 / 504 |
| prostate | 100% | 1216.75 | 245 / 245 | 100% | 4.13 | 501 / 502 |
| adrenal gland | 100% | 922.68 | 258 / 258 | 100% | 6.12 | 229 / 230 |
| kidney | 100% | 912.89 | 89 / 89 | 99% | 5.77 | 896 / 901 |
| stomach | 100% | 732.07 | 359 / 359 | 99% | 4.72 | 284 / 286 |
| intestine | 100% | 1020.80 | 966 / 966 | 99% | 4.50 | 523 / 527 |
| liver | 100% | 781.91 | 226 / 226 | 99% | 3.19 | 401 / 406 |
| pancreas | 98% | 466.55 | 322 / 328 | 99% | 4.29 | 176 / 178 |
| skin | 100% | 824.91 | 1806 / 1809 | 92% | 3.59 | 435 / 472 |
| adipose | 100% | 1342.14 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1471.02 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 5.21 | 29 / 29 |
| muscle | 100% | 2207.77 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1426.56 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 3.85 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.15 | 1 / 1 |
| heart | 99% | 1954.33 | 853 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 84% | 617.25 | 778 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 63% | 1.47 | 50 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0003713 | Molecular function | transcription coactivator activity |
| GO_0003714 | Molecular function | transcription corepressor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0003712 | Molecular function | transcription coregulator activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | YAF2 |
| Protein name | YY1 associated factor 2 YY1-associated factor 2 |
| Synonyms | hCG_1997687 |
| Description | FUNCTION: Binds to MYC and inhibits MYC-mediated transactivation. Also binds to MYCN and enhances MYCN-dependent transcriptional activation. Increases calpain 2-mediated proteolysis of YY1 in vitro. Component of the E2F6.com-1 complex, a repressive complex that methylates 'Lys-9' of histone H3, suggesting that it is involved in chromatin-remodeling. . |
| Accessions | F8W0B9 ENST00000548917.1 ENST00000548661.5 ENST00000547351.5 F8VZR2 A0A0B4J255 G3V1X5 F8VRE5 ENST00000547254.5 G3V219 ENST00000552109.5 ENST00000380790.4 [Q8IY57-3] ENST00000551268.5 ENST00000534854.7 [Q8IY57-1] Q8IY57 ENST00000546726.5 ENST00000552928.5 ENST00000327791.8 [Q8IY57-5] ENST00000555248.2 [Q8IY57-4] G3V212 |